Advice You - Business

... Ronald Coase brought the transaction cost theory to the world...the (market) inefficiencies could be

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

eliminated by organizing transactions within the same organization...

So what you need to do is; optimi

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ze the communication and the interfaces between your company and the sourcing partner:

First of all: minimi

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ze the control. Minimize the amount of control. This control is correlated with the number of exceptions; th

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

e more you can standardize the process the less control you need.

You should also minimize the manual excep

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

tions. If there is a manual interface between the two organizations, make sure this is minimized. The "short

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

cut" in the previous situation where you could knock on the door and solve a problem is no longer possible (

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

too costly).

At last, use the best of both systems. An outsourcing partner has its own configuration or str

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ucture of systems. These systems are designed to in-source large numbers (of transactions); your company is

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

only one of the many that uses this outsourcing partner. The more you can surf along on the standard that is

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

already designed by the existing companies that are connected the fewer problems you will face. And, the mo

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

re cost effective.

These three issues only address the operational situation. What you need to know upfront

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

is that your requirements and those of the sourcing partner match.

And...before you go into the (detailed)

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

design -– do not forget about the inefficiencies.

Outsourcing has only become possible because of the exis

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

tence of a market for those specific business processes. And with the market, there is a price coordinating

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

mechanism.

Yet, that market is based on some characteristics. Standardization is one part of this. If there

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

is no standard, there is no standard price, no benchmark but a lot of inefficiencies that you need to manag

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

e with contracts.

If you design – the outsourcing process – with too many exceptions, because there is no m

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

arket solution (standard) yet, the sourcing will not reduce transaction costs. It rather will increase them.

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/32968/adviceyou-Outsourcing-And-Reducing-Transaction-Costs-End.html">Outsourcing And (Reducing) Transaction Costs (End)</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/32968/adviceyou-Outsourcing-And-Reducing-Transaction-Costs-End.html]Outsourcing And (Reducing) Transaction Costs (End)[/url]

When you have multiple pieces that are all on the same paper and same ink colors you can sometimes gang or put multiple pieces up on the same press sheet. This saves on makeready, setups, plates and washups and can save $$$ if you are comfortable with some of the limitations that you might have.

In the previous article we discussed the over rules of an institution in comparison with the covert rules. Now that you have had time to explore the overt rules thoroughly, it is time for you to explore the covert rules. One must know the overt rules very well, before one can see the covert rules, because they are just about invisible and they are usually in opposition to the overt rules.

The word outsourcing is often heard in the world of business today. It is something which has affected the business of almost every nature and every nation. Outsourcing is occurring in almost every country of this world to some extent. There are some leader countries in this field of outsourcing such as India and China.

Tags

Links

Advice You - Outsourcing And (Reducing) Transaction Costs (End)

Related Articles: